In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract

被引:29
作者
Turiiski, VI
Krustev, AD
Sirakov, VN
Getova, DP
机构
[1] Med Univ, Dept Phys & Biophys, Plovdiv, Bulgaria
[2] Med Univ, Dept Radiol, Plovdiv, Bulgaria
[3] Med Univ, Dept Pharmacol Clin Pharmacol & Drug Toxicol, Plovdiv, Bulgaria
关键词
galantamine; gastrointestinal tract; acetylcholine; acetylcholine receptor;
D O I
10.1016/j.ejphar.2004.07.054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Galantamine is efficacious for vascular dementia and Alzheimer's disease. Its application leads to some negative gastrointestinal side effects. The present study observes galantamine-induced influence on gastrointestinal motility of rats and its effects on isolated gastrointestinal smooth muscles. The gastrointestinal tract was studied by X-ray contrast examination. Functional disturbances were observed: hypertonia, increased stomach and ileal peristalsis activity, accelerated intestinal passage. In vitro, the drug caused tonic contractions in smooth muscle preparations and increased the gastric and ileal phasic amplitude. The jejunal smooth muscle strips demonstrated an opposite tendency. The reactions were a result of the interaction of galantamine-accumulated endogenic acetylcholine with M- and N-acetylcholine receptors. The tonic effects were influenced in varying degree by atropine and ipratropium, whereas the phasic by atropine, ipratropium, hexametonium and methysergide. In conclusion, the in vitro effects registered satisfactorily explain in vivo examined galantamine-induced changes in the gastrointestinal tract of the treated rats and can be considered as main cause for development of such changes. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 21 条
[1]  
BOLLAN B, 1995, THESIS U CATHOLIQUE, P14
[2]   NEURONAL NITRIC-OXIDE IN THE GUT [J].
BROOKES, SJH .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (06) :590-603
[3]  
Corey-Bloom J, 2003, INT J CLIN PRACT, V57, P219
[4]   Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: Effects on the course of Alzheimer's disease [J].
Coyle, J ;
Kershaw, P .
BIOLOGICAL PSYCHIATRY, 2001, 49 (03) :289-299
[5]   Use of cholinesterase inhibitors in clinical practice - Evidence-based recommendations [J].
Cummings, JL .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 11 (02) :131-145
[6]   Inhibition of human cholinesterases by drugs used to treat Alzheimer disease [J].
Darvesh, S ;
Walsh, R ;
Kumar, R ;
Caines, A ;
Roberts, S ;
Magee, D ;
Rockwood, K ;
Martin, E .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2003, 17 (02) :117-126
[7]   Distribution of serotonin-immunoreactive nerve cells and fibers in the rat gastrointestinal tract [J].
Fujimiya, M ;
Okumiya, K ;
Yamane, T ;
Maeda, T .
HISTOCHEMISTRY AND CELL BIOLOGY, 1997, 107 (02) :105-114
[8]   Galanthamine [J].
Fulton, B ;
Benfield, P .
DRUGS & AGING, 1996, 9 (01) :60-65
[9]   Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease [J].
Maelicke, A ;
Samochocki, M ;
Jostock, R ;
Fehrenbacher, A ;
Ludwig, J ;
Albuquerque, EX ;
Zerlin, M .
BIOLOGICAL PSYCHIATRY, 2001, 49 (03) :279-288
[10]   Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease [J].
Maelicke, A .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 :11-18